InvestorsHub Logo

Nemesis18

05/17/24 8:49 AM

#692228 RE: learningcurve2020 #692227

What's the added cost for Polly and will they still use chemo rad too? Since there are no quarterly calls and the CEO doesn't do presentations, perhaps you can tell us How's NICE to think about cost?



The NICE Accountants are still laughing the arses off about the cost vs benefit ratio of DCVAX-L based on the published P3 firstly, and secondly, the real world data coming back now from patients paying £250,000, only for the cancer to comeback with NO extension to OS.